Envista Holdings (NVST) Capital Expenditures Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -11.41% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 9.65% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 61.83% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -63.39% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 14.32% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 21.73% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 12.30% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 15.01% |
| 10 | Envista Holdings | 3.87 Bn | 2.79 Bn | 390.10 Mn | 111.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 111.86% |
| Dec 31, 2025 | 89.53% |
| Sep 26, 2025 | 45.95% |
| Jun 27, 2025 | 80.88% |
| Mar 28, 2025 | -46.36% |
| Dec 31, 2024 | 4.88% |
| Sep 27, 2024 | -59.78% |
| Jun 28, 2024 | -51.77% |
| Mar 29, 2024 | -37.14% |
| Dec 31, 2023 | -51.48% |
| Sep 29, 2023 | -31.60% |
| Jun 30, 2023 | 16.53% |
| Mar 31, 2023 | -11.62% |
| Dec 31, 2022 | 94.25% |
| Sep 30, 2022 | 53.71% |
| Jul 1, 2022 | -40.10% |
| Apr 1, 2022 | 138.55% |
| Dec 31, 2021 | -33.59% |
| Oct 1, 2021 | 32.58% |
| Jul 2, 2021 | 158.97% |
| Apr 2, 2021 | -38.97% |
| Dec 31, 2020 | -17.61% |
| Oct 2, 2020 | -33.33% |
| Jul 3, 2020 | -70.57% |
| Apr 3, 2020 | -12.82% |
| Dec 31, 2019 | -50.31% |